TMEPAI is associated with metastatic disease [18] and has been reported to enhance TGFβ-induced migration and an epithelial-to-mesenchymal transition (EMT) in early and late stage tumors of the breast and lung [18], [49]. Here, TGFB1 is linked to metastatic neoplasm.